Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Spruce Biosciences (SPRB) Current Assets (2022 - 2025)

Spruce Biosciences (SPRB) has disclosed Current Assets for 4 consecutive years, with $52.1 million as the latest value for Q4 2025.

  • Quarterly Current Assets rose 17.88% to $52.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $52.1 million through Dec 2025, up 17.88% year-over-year, with the annual reading at $52.1 million for FY2025, 17.88% up from the prior year.
  • Current Assets for Q4 2025 was $52.1 million at Spruce Biosciences, up from $14.5 million in the prior quarter.
  • The five-year high for Current Assets was $137.2 million in Q1 2023, with the low at $14.5 million in Q3 2025.
  • Average Current Assets over 4 years is $76.8 million, with a median of $84.7 million recorded in 2022.
  • The sharpest move saw Current Assets skyrocketed 44.31% in 2023, then plummeted 77.17% in 2025.
  • Over 4 years, Current Assets stood at $83.6 million in 2022, then grew by 22.22% to $102.2 million in 2023, then crashed by 56.74% to $44.2 million in 2024, then rose by 17.88% to $52.1 million in 2025.
  • According to Business Quant data, Current Assets over the past three periods came in at $52.1 million, $14.5 million, and $21.0 million for Q4 2025, Q3 2025, and Q2 2025 respectively.